CorMedix (CRMD) Change in Accured Expenses (2010 - 2025)

CorMedix has reported Change in Accured Expenses for 16 years, with the latest figure at $52.3 million in Q4 2025.

• Quarterly Change in Accured Expenses rose 248.94% year-over-year to $52.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $100.8 million (up 338.42% YoY) and the FY2025 annual result came in at $100.8 million, up 338.42% from the prior year.
• Change in Accured Expenses declined to $52.3 million in Q4 2025 per CRMD's latest filing, from $54.7 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $54.7 million in Q3 2025 and troughed at -$6.6 million in Q2 2025.
• A 5-year average of $6.4 million and a median of $584721.5 in 2021 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses surged 2917.47% in 2022, then slumped 723.09% in 2025.
• Over 5 years, Change in Accured Expenses stood at -$28656.0 in 2021, then soared by 2917.47% to $807375.0 in 2022, then jumped by 126.72% to $1.8 million in 2023, then surged by 718.48% to $15.0 million in 2024, then jumped by 248.94% to $52.3 million in 2025.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $52.3 million, $54.7 million, and -$6.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.